2018
DOI: 10.1097/txd.0000000000000848
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant

Abstract: BackgroundThe development of HLA antibodies towards a failing renal allograft is a barrier to retransplantation. This study aimed to compare the formation of HLA donor-specific antibodies (DSA) in patients undergoing graft nephrectomy and in those with a failed graft left in situ who had maintenance immunosuppression (IS) stopped, and assess the relative impact of IS cessation and graft nephrectomy on future relative chance of transplant (R-CoT).MethodsA single-center retrospective study of patients with faile… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
26
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 28 publications
0
26
0
Order By: Relevance
“…DSAs were also measured before and after graft nephrectomy in those in which it was performed. An increase in antibody titer was observed in those patients with IS withdrawal, and this titer was higher in patients with graft nephrectomy [32].…”
Section: Introductionmentioning
confidence: 86%
“…DSAs were also measured before and after graft nephrectomy in those in which it was performed. An increase in antibody titer was observed in those patients with IS withdrawal, and this titer was higher in patients with graft nephrectomy [32].…”
Section: Introductionmentioning
confidence: 86%
“…In cases of previous transplant, whether the graft is in situ or not, the Luminex SAB testing is always performed on a day of transplant sample before kidney implantation. This is because HLA antibody profiles of patients with previous donor material still present can change rapidly as immunosuppression is tapered or stopped . For all sensitised patients a wet XM is performed retrospectively. Sensitised patients where analysis of recent or historic Luminex SAB data indicates the presence of a potential HLA‐DSA.…”
Section: Xm Omission In Scotlandmentioning
confidence: 99%
“…The recommendation is to perform a final “wet” pre‐transplant XM within 14 days prior to the transplant date. If the patient is sensitised or their antibody profile changes during the period between the vXM and final XM, for example due to changes in immunosuppression, an intermediate “wet” crossmatch may take place. The patient has antibodies reactive with donor mismatches with cumulative MFI <5000 (+/−) or that may represent reactivity against denatured antigen and the vXM is positive. The recommendation will be to perform a full “wet” XM to assess compatibility further.…”
Section: Use Of Vxm For Living Donor Transplantationmentioning
confidence: 99%
See 2 more Smart Citations